Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global deep brain stimulation device market was valued at US$ 1.03 billion in 2021 and is expected to register a revenue CAGR of 9.60% to reach US$ 2.35 billion by 2030.

Deep Brain Stimulation Device Market Fundamentals

A deep brain stimulation device is used to treat patients with neurological diseases, such as Parkinson’s disease (PD), obsessive-compulsive disorder, and epilepsy. The device generates electrical impulses that help in the regulation of irregular impulses. The technique is only recommended when the medication approach is no longer applicable or is ineffective to treat the condition. 

[674234234]

Deep Brain Stimulation Device Market Dynamics

The global deep brain stimulation device market is expected to register significant revenue growth during the forecast period. This can be attributed to rising cases of depression, increasing prevalence of involuntary movement diseases, rising R&D activities focused on the development of effective treatment solutions for neurological diseases, increasing adoption of novel treatment technologies, and rising geriatric population prone to neurological disabilities. Moreover, the market revenue growth is being driven by increase in preference for slightly invasive operating procedures and rise in the number of neurological disorders.

However, risks of allergic reactions and infections and availability of alternatives, such as surgeries and drug therapies, are likely to limit the revenue growth of this market in the next few years. 

Deep Brain Stimulation Device Market Ecosystem

The global deep brain stimulation device market is analyzed based on four parameters: products, applications, end user, and region.

Global Deep Brain Stimulation Device Market by Product 

[675543242]

Based on the product, the global deep brain stimulation device market is segmented into single-channel and dual-channel.

The dual-channel devices segment dominates the global market, owing to high safety profile and wider usage of dual-channel devices in surgical procedures. Demand for single-channel devices is expected to grow significantly in the next few years, as these devices can provide neurologists with a wide range of programming options.

Global Deep Brain Stimulation Device Market by Application

Based on the application, the global deep brain stimulation device market is segmented into pain management, Parkinson’s disease (PD), epilepsy, dystonia, depression, essential tremor, and obsessive-compulsive disorder (OCD).

The Parkinson’s disease segment dominates the market, due to presence of a large patient base suffering from this disorder. According to Jun 2022 report by the World Health Organization (WHO), there has been a more than two-fold rise in the cases of PD in the past 25 years. As per the 2019 estimates, there were over 8.5 million people worldwide who have Parkinson's disease. Moreover, PD caused 5.8 million disability-adjusted life years in 2019, increase of 81% since 2000, and 3,29,000 deaths, increase of over 100% since 2000. Furthermore, increase in awareness about treatment solutions available for PD and technological advancements resulting in development of products with advanced features are expected to boost revenue growth in the market.

Global Deep Brain Stimulation Device Market by Region

Based on the region, the global deep brain stimulation device market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW).

North America dominates the global market, owing to the presence of advanced healthcare infrastructure, high prevalence of neurological disorders, such as PD and epilepsy, and increase in government initiatives favoring treatment and management of neurological diseases. The National Institute of Neurological Disorders and Stroke (NINDS), established by the U.S National Institute of Health, aims at the development of techniques that help in monitoring neurological disease progression. It has also funded research and collected human samples and clinical data for the discovery of biomarkers, which are likely to help in improving the development of new therapeutics. 

The market in Asia Pacific is projected to register revenue growth at a significant pace during the forecast period. This can be ascribed to rise in the number of patients suffering from neurodegenerative diseases, improved clinical practices, increase in preference toward usage of devices in treatment despite surgical operations, rise in geriatric population which is more prone to neurological diseases.

Deep Brain Stimulation Device Market Competitive Landscape

The prominent players operating in the global deep brain stimulation device market include: -

• Boston Scientific Corporation
• Abbott Laboratories Inc
• Aleva Neurotherapeutics SA
• Medtronic Plc
• Neuropace Inc
• Livanova Plc
• Nexstim OY
• Beijing PINS Medical Co. Ltd
• Functional Neuromodulation Ltd
• Sapiens Labs Pvt. Ltd

Deep Brain Stimulation Device Market Strategic Developments

• In June 2021, Medtronic plc announced that the Sen Sight Directional Lead System for DBS therapy has received approval from the U.S. FDA. This approval helped the company to strengthen its product portfolio.
• In January 2020, Abbott’s Infinity Deep Brain Stimulation (DBS) device received FDA approval for an expanded indication that can now specifically target the internal globus pallidus. This therapy aids in symptom reduction of individuals with Parkinson’s disease. 

Frequently Asked Questions About This Report